Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

According to Jefferies, Anthem Inc (ANTM) may pull back from a portion of its Obamacare individual insurance markets in 2018. The announcement came almost a week after Republicans pulled legislation to review US health care. Health insurance companies such as Humana Inc, Aetna Inc and UnitedHealth Group Inc have already pulled out from Obamacare markets, after posting tremendous losses.

Anthem shares closed higher for a third straight trading session on Thursday. The stock went up 1.27% ($2.10) to $167.08, after touching an intraday high at $167.83, or a price level not seen since March 21st ($168.50). In the week ended on March 26th the shares of the health benefit company lost 3.28% of their market value compared to a week ago, which marked the first drop in the past five weeks and also the worst performance since the week ended on August 28th 2016. However, the stock has extended its advance to 1.37% so far during the current month, following a 6.93% surge in February. The latter has been a fourth straight month of gains. For the entire past year, Anthem shares soared 3.11%.

According to a March 30th client note by Jefferies, Anthem was considering to exit a “high percentage” of the 144 rating regions, where it takes part at present.

As reported by Reuters, the mix of ill and healthy customers has been worse than expected, with premium rates on the individual insurance market being up 25% in 2017.

“We continue to actively pursue policy changes that will help with market stabilization and achieve the common goal of making quality health care more affordable and accessible for all”, Anthem Inc said in a statement, cited by the same media.

Daily and Weekly Pivot Levels

With the help of the Camarilla calculation method, todays levels of importance for the Anthem stock are presented as follows:

R1 – $167.37
R2 – $167.66
R3 (Range Resistance – Sell) – $167.95
R4 (Long Breakout) – $168.81
R5 (Breakout Target 1) – $169.82
R6 (Breakout Target 2) – $170.28

S1 – $166.79
S2 – $166.50
S3 (Range Support – Buy) – $166.21
S4 (Short Breakout) – $165.35
S5 (Breakout Target 1) – $164.34
S6 (Breakout Target 2) – $163.88

By using the traditional method of calculation, the weekly levels of importance for Anthem Inc (ANTM) are presented as follows:

Central Pivot Point – $164.26
R1 – $167.00
R2 – $171.22
R3 – $173.95
R4 – $176.67

S1 – $160.03
S2 – $157.30
S3 – $153.07
S4 – $148.83

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • NZD/USD slid after Chinese PMI, FOMCNZD/USD slid after Chinese PMI, FOMC New Zealand dollar retreated against its US counterpart on Thursday, although a report showed that Chinese advance manufacturing PMI rose more than projected in August.NZD/USD fell to its lowest point today at 0.7808 at 0:20 GMT, after […]
  • NZD/USD on positive territoryNZD/USD on positive territory New Zealand dollar traded higher against its US counterpart on Monday, as the greenback was pressured after the downbeat US non-farm payrolls data, published on Friday.NZD/USD climbed to its highest point today at 0.8014 at 8:48 GMT, after […]
  • Gold trading outlook: futures extend gains on US rates speculationsGold trading outlook: futures extend gains on US rates speculations Gold for delivery in December rose on Monday, extending the biggest weekly advance since mid-June, amid speculations Chinas currency devaluation last week may prompt the Federal Reserve not to raise interest rates in September, while the Asian […]
  • Copper falls on weak China data and QE outlookCopper falls on weak China data and QE outlook Copper fell on Thursday as decreased demand outlook from the metals biggest consumer, China, weighed on prices. Investors also laid eyes on tomorrows key U.S. economic data that is expected to be on track withs Fed projections as a step […]
  • ImmunoGen appoints new Chief Financial OfficerImmunoGen appoints new Chief Financial Officer ImmunoGen Inc, a leading firm in the expanding field of antibody-drug conjugates (ADCs) for cancer treatment, said on Monday that it had appointed Lauren White as its next Senior Vice President and Chief Financial Officer.White brings […]
  • Natural gas trading outlook: futures unchanged amid rising temperatures in the USNatural gas trading outlook: futures unchanged amid rising temperatures in the US Natural gas futures were little changed during early trade in Europe today. Rising temps over top-consumer US are set to limit upcoming gains for natural gas inventories. The official report on stockpiles levels is due tomorrow.Front month […]